EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2

Erendira Villalobos-Sánchez iD, Daniel García-Ruiz, Tanya A Camacho-Villegas iD, Alejandro A Canales-Aguirre iD, Abel Gutiérrez-Ortega iD, José E Muñoz-Medina iD, Darwin E Elizondo-Quiroga iD

Viruses · 11.05.2023 · 15 (5) · 1155

DOI: 10.3390/v15051155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 11.05.2023. Verfasst von Erendira Villalobos-Sánchez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical and Pharmaceutical Biotechnology Unit, Center of Research and Assistance in Technology and Design of the State of Jalisco, Guadalajara 44270,…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONACYT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronavirus infectious disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has been spreading rapidly worldwide, creating a pandemic. This article describes the evaluation of the antiviral activity of nordihydroguaiaretic acid (NDGA), a molecule found in Creosote bush (Larrea tridentata) leaves, against SARS-CoV-2 in vitro. A 35 µM concentration of NDGA was not toxic to Vero cells and exhibited a remarkable inhibitory effect on the SARS-CoV-2 cytopathic effect, viral plaque formation, RNA replication, and expression of the SARS-CoV-2 spike glycoprotein. The 50% effective concentration for NDGA was as low as 16.97 µM. Our results show that NDGA could be a promising therapeutic candidate against SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19AnimalsChlorocebus aethiopsMasoprocolAntiviral AgentsVero Cells

Stichwörter der Autor:innen

Larrea tridentataNDGASARS-CoV-2 antivirals

Substanzen

MasoprocolAntiviral Agents

Autor:innen und Institutionen

  • Medical and Pharmaceutical Biotechnology Unit, Center of Research and Assistance in Technology and Design of the State of Jalisco, Guadalajara 44270, Mexico.
  • CONACYT, Medical and Pharmaceutical Biotechnology Unit, Center of Research and Assistance in Technology and Design of the State of Jalisco, Guadalajara 44270, Mexico.
  • Coordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguros Social, México City 27170, Mexico.

ORCID-Profile: Erendira Villalobos-Sánchez, Tanya A Camacho-Villegas, Alejandro A Canales-Aguirre, Abel Gutiérrez-Ortega, José E Muñoz-Medina, Darwin E Elizondo-Quiroga

Förderung

  • CONACYT

Zitieren

APA

Villalobos-Sánchez, E., García-Ruiz, D., Camacho-Villegas, T. A., Canales-Aguirre, A. A., Gutiérrez-Ortega, A., Muñoz-Medina, J. E., & Elizondo-Quiroga, D. E. (2023). In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2. Viruses, 15(5), 1155. https://doi.org/10.3390/v15051155

Vancouver

Villalobos-Sánchez E, García-Ruiz D, Camacho-Villegas TA, Canales-Aguirre AA, Gutiérrez-Ortega A, Muñoz-Medina JE, et al. In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2. Viruses. 2023;15(5):1155. doi:10.3390/v15051155

BibTeX
@article{VillalobosSnchez2023,
  author = {Villalobos-Sánchez, Erendira and García-Ruiz, Daniel and Camacho-Villegas, Tanya A and Canales-Aguirre, Alejandro A and Gutiérrez-Ortega, Abel and Muñoz-Medina, José E and Elizondo-Quiroga, Darwin E},
  title = {In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {1155},
  doi = {10.3390/v15051155}
}
Kostenlos starten →